Surgical treatment of pancreatic ductal adenocarcinoma

• Verfasst von: Wei, Kongyuan [VerfasserIn]
• Verfasst von: Hackert, Thilo [VerfasserIn]
• Titel: Surgical treatment of pancreatic ductal adenocarcinoma
• Verf.angabe: Kongyuan Wei and Thilo Hackert
• E-Jahr: 2021
• Jahr: 20 April 2021
• Umfang: 16 S.
• Fussnoten: Gesehen am 01.06.2021
• Titel Quelle: Enthalten in: Cancers
• Ort Quelle: Basel : MDPI, 2009
• Jahr Quelle: 2021
• Band/Heft Quelle: 13(2021), 8, Artikel-ID 1971, Seite 1-16
• ISSN Quelle: 2072-6694
• DOI: doi:10.3390/cancers13081971
• Datenträger: Online-Ressource
• Sprache: eng
• Sach-SW: pancreatic ductal adenocarcinoma
• Sach-SW: surgical treatment
• Sach-SW: technical advances
• K10plus-PPN: 1759318620

Abstract

Pancreatic ductal adenocarcinoma (PDAC) represents an aggressive tumor of the digestive system with still low five-year survival of less than 10%. Although there are improvements for multimodal therapy of PDAC, surgery still remains the effective way to treat the disease. Combined with adjuvant and/or neoadjuvant treatment, pancreatic surgery is able to enhance the five-year survival up to around 20%. However, pancreatic resection is always associated with a high risk of complications and regarded as one of the most complex fields in abdominal surgery. This review gives a summary on the surgical treatment for PDAC based on the current literature with a special focus on resection techniques.